Key facts
- This page summarizes James G. Hall's Form 4 filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Jun 2023, 15:27.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
Additional SEC filing notes
Footnote F1
The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
Footnote F2
Restricted Stock Units will vest on the 3rd anniversary of the grant date.
Footnote F3
Restricted Stock Units will vest on the 3rd anniversary of the grant date or if earlier, upon a Change in Control.